Forget 3D Systems Corporation and Stratasys, Ltd.: This Is the 3-D Printing Company I Just Bought
Brian Stoffel, The Motley Fool - Motley Fool - Fri Apr 18, 9:01AM CDT
The current year has not been a kind one for investors in 3-D printing companies. In fact, shares of the two largest players in the field, 3D Systems and Stratasys , were down 50% and 30%, respectively, by the start of this week. Does that...
Analysts View on Biotech Equities -- Research on Organovo Holdings, BioMarin Pharma, Vertex Pharma, and Spectrum Pharma
PR Newswire - Tue Apr 15, 10:15AM CDT
On Monday, April 14, 2014, the NASDAQ Composite ended at 4,022.69, up 0.57%, the Dow Jones Industrial Average advanced 0.91%, to finish the day at 16,173.24, and the S&P 500 closed at 1,830.61, up 0.82%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 648.05, up 0.51%, while the same has fallen by 1.86% in the previous three months. Investor-Edge has initiated coverage on the following equities: Organovo Holdings Inc. (NYSE MKT: ONVO), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) and Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI). Free technical research on ONVO, BMRN, VRTX and SPPI can be downloaded upon signing up at:
Organovo Comments on Misleading and Inaccurate Reports
PR Newswire - Tue Apr 15, 7:05AM CDT
Organovo Holdings, Inc. (NYSE MKT: ONVO), the San Diego-based regenerative medicine company focused on using its breakthrough NovoGen 3D human tissue printing technology to create tissue on demand for medical research and therapeutic applications, today commented on recent reports published by two unaffiliated firms:
Why Organovo Holdings, Gogo, and National Bank of Greece Tumbled Today
Dan Caplinger, The Motley Fool - Motley Fool - Mon Apr 14, 7:35PM CDT
For those investors who feared further losses after last week's declines, Monday provided some relief, with major-market indexes rising almost 1% on the day. Positive news on the economic front helped to bolster investor confidence, but it did little...
Global 3D Printing Market 2013-2020: New Technology, Materials & Applications Analysis
M2 - Mon Apr 14, 4:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mvhssr/3d_printing) has announced the addition of the "Global 3D Printing Market 2013-2020: New Technology, Materials & Applications Analysis" report to their offering. In this report, the global 3D printing is segmented on the basis of technology, material, application, and geography. The technology segment comprises of Stereo lithography (SLA), Laser Sintering, Electron Beam Melting (EBM), Fused Disposition Modeling (FDM), Laminated Object manufacturing (LOM), Three Dimensional Inkjet printing (3DP), and other proprietary technologies. The global 3D printing market by material comprises polymers, metals/alloys, and others (ceramics, sand, and paper). The application segment includes aerospace industry, automotive consumer products, healthcare, government and defense, industrial/business machines, education & research, and others (arts, architecture). Healthcare and aerospace are the two fastest growing application areas for 3D printing. The stringent requirements such as light weight and accurate & precise design requirements for airplanes parts are the major driving factors behind the growth of 3D printing in the aerospace industry, over traditional manufacturing methods. However, the increasing medical procedures' volumes due to the growing population, rising income levels, low labor costs, and increasing health awareness are responsible for the tremendous growth of 3D printing in healthcare sector, as well. The competitive landscape segment in the report covers all the key growth strategies of several major players as well as startups in the global 3D printing market; including 3D Systems (U.S.), Stratasys (U.S.), Renishaw (U.K.), EnvisionTEC (Germany), Optomec (U.S.), SLM Solutions (Germany), LayerWise (Belgium), ExOne (U.S.), EOS GmbH (Germany), Organovo Holdings (U.S.), and Arcam (Sweden), among others. Scope of the report Applications: 3D printing is used for various applications such as in the automotive, aerospace, consumer, healthcare, government & defense, industrial, and education and research sectors. Technologies: In this research report, the 3D printing technology is segregated into Stereo lithography (SLA), Laser Sintering, Electron Beam Melting (EBM), Fused Disposition Modeling (FDM), Laminated Object manufacturing (LOM), Three Dimensional Inkjet printing (3DP), and the likes. Materials: The materials used in 3D Printer are polymers, metals & alloys, powder, and others. The metals' based 3D printing holds the future prospect of the market. Key Topics Covered: - Introduction - Executive Summary - Cover Story - 3D Printing Market Overview - 3D Printing Technology Market - 3D Printing Materials Market - Market By Application - Market By Geography - Competitive Landscape - Company Profiles - 3D Systems - 3T Rpd - Arcam Ab - Autodesk - Concept Laser - Envisiontec Gmbh - Eos - Esma - Exone - Gpi Prototype& Manufacturing Services Inc - Hoganas Ab - Layerwise - Luxexcel - Materialise Nv - Mcor Technologies Ltd - Microtec Gesellschaft F?r Mikrotechnologie Mbh - Optomec Inc - Organovo Holdings - Ponoko - Stratasys, Inc - Voxeljet Ag Visit http://www.researchandmarkets.com/research/mv...d_printing
5 Innovations Wall Street and Investors Don't Understand How to Value
Sean Williams, The Motley Fool - Motley Fool - Sun Apr 13, 10:31AM CDT
Innovation is the cornerstone to any successful business . From automakers and restaurants to mobile device makers and biotech companies, innovation is what separates one company from the next. It's also what drives revenue and profits for a company...
Organovo Holdings Inc Founder: We May Not Print Organs, but That Won't Matter
Brian Stoffel, The Motley Fool - Motley Fool - Wed Apr 09, 1:30PM CDT
Imagine the ability to create a fully functioning human organ using a 3-D bioprinter. Even though it's not a key piece of the technology Organovo Holdings Inc is counting on for revenue any time soon, it's still how many investors -- myself...
Organovo Holdings, Inc. to Webcast, Live, at RetailInvestorConferences.com April 10th
CNW Group - Tue Apr 08, 9:20AM CDT
Company invites Main Street and Wall Street investors to attend interactive real-time virtual conference
Organovo to Present at the 13th Annual Needham Healthcare Conference
PR Newswire - Wed Apr 02, 7:05AM CDT
Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"
5 of Last Week's Biggest Losers
Rick Munarriz, The Motley Fool - Motley Fool - Sun Mar 30, 7:30AM CDT
There's never a shortage of losers in the stock market. Let's take a closer look at five of this past week's biggest sinkers. Company March 28 Weekly Loss Exelixis $3.38 46% MannKind ...
'Mad Money' Lightning Round: Sell Starbucks at $72
at The Street - Sat Mar 29, 5:00AM CDT
Cramer prefers Boeing over AerCap Holdings and CBS Outdoor over Chambers Street Properties.
Jim Cramer's 'Mad Money' Recap: Next Week's Game Plan
at The Street - Fri Mar 28, 7:21PM CDT
Cramer says the market needs both a China stimulus plan and positive U.S. employment numbers to sustain any gains.
Organovo Provides Guidance on Retail Investor Conference
PR Newswire - Fri Mar 28, 7:05AM CDT
Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"
Coverage of Health Care Equities -- Research on Quest Diagnostics, Organovo, Agilent Technologies, and Thermo Fisher Scientific
PR Newswire - Tue Mar 25, 10:12AM CDT
The trading session on Monday, March 24, 2014 ended on a negative note as the Dow Jones Industrial Average finished at 16,276.69, down 0.16% and the NASDAQ Composite closed at 4,226.39, down 1.18%. The S&P 500 finished the session 0.49% lower at 1,857.44. The losses were broad based as eight out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index finished the day at 666.18, down 1.41% and the same has fallen by 2.67% in the last one month. Investor-Edge has initiated coverage on the following equities: Quest Diagnostics Inc. (NYSE: DGX), Organovo Holdings Inc. (NYSE MKT: ONVO), Agilent Technologies Inc. (NYSE: A), and Thermo Fisher Scientific Inc. (NYSE: TMO). Free technical research on DGX, ONVO, A, and TMO can be downloaded upon signing up at:
Health Care Stocks Review -- Research on Quest Diagnostics, Organovo Holdings, Agilent Technologies, and Thermo Fisher Scientific
PR Newswire - Mon Mar 24, 10:01AM CDT
On Friday, March 21, 2014, the NASDAQ Composite finished at 4,276.79, down 0.98%. The Dow Jones Industrial Average closed the session at 16,302.77, down 0.17% and the S&P 500 ended the day at 1,866.52, lower by 0.29%. Four out of ten sectors ended the session in negative. The S&P 500 Health Care Sector Index finished the day 1.54% lower at 675.70 and the same has declined 1.28% in the last one month. Investor-Edge has initiated coverage on the following equities: Quest Diagnostics Inc. (NYSE: DGX), Organovo Holdings Inc. (NYSE MKT: ONVO), Agilent Technologies Inc. (NYSE: A) and Thermo Fisher Scientific Inc. (NYSE: TMO). Free technical research on DGX, ONVO, A and TMO can be downloaded upon signing up at:
Organovo Holdings, Inc. To Present At Regen Med Investor Day March 26 In New York
PR Newswire - Mon Mar 24, 7:05AM CDT
Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"
7 Undeniable Reasons to Invest in Health Care
Keith Speights, The Motley Fool - Motley Fool - Sat Mar 22, 7:00AM CDT
You need to be in health care. There are no ifs, ands, or buts about it. I'm not talking about working in the health-care industry (although that's not a bad idea, either). At least part of your investment portfolio needs to be in health care...
'Mad Money' Lightning Round: Happy to Own Sirius
at The Street - Wed Mar 19, 5:00AM CDT
Cramer likes Organovo Holdings, Vodafone and Primerica but he'd take profits in Exact Sciences.
Jim Cramer's 'Mad Money' Recap: Profits Still Matter
at The Street - Tue Mar 18, 7:07PM CDT
Once the hedge fund managers realized there was no bad news coming from Russia or China, they started buying U.S. stocks, Cramer says.